Heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial medical management
暂无分享,去创建一个
[1] D. Schriger,et al. Annals of Emergency Medicine Journal Club. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment. Answers to May 2008 journal club questions. , 2008, Annals of emergency medicine.
[2] M. Massin,et al. Epidemiology of Heart Failure in a Tertiary Pediatric Center , 2008, Clinical cardiology.
[3] W. Poller,et al. Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy , 2008, Journal of medical virology.
[4] J. Towbin,et al. Worsening renal function in children hospitalized with decompensated heart failure: Evidence for a pediatric cardiorenal syndrome?* , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[5] C. Yancy,et al. Noninvasive ventilation outcomes in 2,430 acute decompensated heart failure patients: an ADHERE Registry Analysis. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[6] M. Santoro,et al. Congenital heart disease in live-born children: incidence, distribution, and yearly changes in the Campania Region , 2008, Journal of cardiovascular medicine.
[7] G. Taylor,et al. Pediatric Myocarditis: Emergency Department Clinical Findings and Diagnostic Evaluation , 2007, Pediatrics.
[8] D. Pennell,et al. Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy , 2007, Journal of magnetic resonance imaging : JMRI.
[9] G. Breithardt,et al. Chronic kidney disease in patients with chronic heart failure--impact on intracardiac conduction, diastolic function and prognosis. , 2007, International journal of cardiology.
[10] W. Gersony,et al. Spontaneous regression of left ventricular dilation in children with restrictive ventricular septal defects. , 2007, The Journal of pediatrics.
[11] D. Atar,et al. [Treatment of congestive heart failure]. , 2007, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[12] L. Lehtonen,et al. The utility of levosimendan in the treatment of heart failure , 2007, Annals of medicine.
[13] C. Yancy,et al. Beyond diuretics: management of volume overload in acute heart failure syndromes. , 2006, The American journal of medicine.
[14] H. Caron,et al. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. , 2006, European journal of cancer.
[15] S. Colan,et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. , 2006, JAMA.
[16] S. Colan,et al. Factors Associated With Establishing a Causal Diagnosis for Children With Cardiomyopathy , 2006, Pediatrics.
[17] K. Aaronson,et al. Risk of death associated with nesiritide in patients with acutely decompensated heart failure. , 2006, JAMA.
[18] L. Shekerdemian,et al. Early experience with Levosimendan in children with ventricular dysfunction* , 2006, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[19] B. Byrne,et al. Cardiac and Clinical Phenotype in Barth Syndrome , 2006, Pediatrics.
[20] M. Lesch,et al. Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis: historical analysis, review of the literature, and a postulated unifying hypothesis. , 2006, Progress in cardiovascular diseases.
[21] Harlan M Krumholz,et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. , 2006, Journal of the American College of Cardiology.
[22] D. Winlaw,et al. Levosimendan for Low Cardiac Output: A Pediatric Experience , 2006, Journal of intensive care medicine.
[23] Barry J Maron,et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.
[24] P. Chetaille,et al. Outcome of acute fulminant myocarditis in children , 2006, Heart.
[25] R. Michler,et al. Perioperative Effects and Safety of Nesiritide Following Cardiac Surgery in Children , 2006, Journal of intensive care medicine.
[26] H. Schultheiss,et al. Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction , 2005, Circulation.
[27] C. O'connor,et al. Overview of current noninodilator therapies for acute heart failure syndromes. , 2005, The American journal of cardiology.
[28] M. Gheorghiade,et al. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. , 2005, The American journal of cardiology.
[29] E. Topol. Nesiritide - not verified. , 2005, The New England journal of medicine.
[30] K. Adams,et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, Journal of the American College of Cardiology.
[31] L. Moreno,et al. Cardiac findings in adolescents with anorexia nervosa at diagnosis and after weight restoration , 2005, European Journal of Pediatrics.
[32] D. O'Leary,et al. Impaired muscle metaboreflex-induced increases in ventricular function in heart failure. , 2004, American journal of physiology. Heart and circulatory physiology.
[33] M. Fisher,et al. Nesiritide Does Not Improve Renal Function in Patients With Chronic Heart Failure and Worsening Serum Creatinine , 2004, Circulation.
[34] M. Burch. Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence , 2004, Heart.
[35] E. Pesonen,et al. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery , 2004, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[36] J. Towbin,et al. Echocardiographic predictors of adverse clinical events in children with dilated cardiomyopathy: a prospective clinical study , 2004, Heart.
[37] J. Tyberg,et al. Effects of Exogenous and Endogenous Natriuretic Peptides on Forearm Vascular Function in Chronic Heart Failure , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[38] N. Akkök,et al. Cardiac abnormalities in children with systemic lupus erythematosus. , 2003, The Turkish journal of pediatrics.
[39] F. Muntoni. Cardiomyopathy in muscular dystrophies , 2003, Current opinion in neurology.
[40] H. Schultheiss,et al. Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction , 2003 .
[41] E John Orav,et al. The incidence of pediatric cardiomyopathy in two regions of the United States. , 2003, The New England journal of medicine.
[42] Christopher M O'Connor,et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. , 2003, Journal of the American College of Cardiology.
[43] D. Nelson,et al. Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart Disease , 2003, Circulation.
[44] N. Freemantle,et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure—a meta‐regression analysis , 2002, European journal of heart failure.
[45] C. Jurkovitz,et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. , 2002, Journal of the American Society of Nephrology : JASN.
[46] J. Hoffman,et al. The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.
[47] R. Califf,et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. , 2002, JAMA.
[48] F. Alla,et al. Treatment of Congestive Heart Failure: Interfering the Aldosterone-Cardiac Extracellular Matrix Relationship , 2001, Hypertension.
[49] B. Clark,et al. Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus. , 2001, The Journal of rheumatology.
[50] R. Yates,et al. Dilated cardiomyopathy in dystrophic epidermolysis bullosa , 2000, Archives of disease in childhood.
[51] X Marchandise,et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. , 1998, Journal of the American College of Cardiology.
[52] G. Wiesner,et al. Cardiac Disease in Costello Syndrome , 1998, Pediatrics.
[53] O. Simell,et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. , 1997, American journal of epidemiology.
[54] B Maisch,et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.
[55] D. Sillence,et al. X linked fatal infantile cardiomyopathy maps to Xq28 and is possibly allelic to Barth syndrome. , 1995, Journal of medical genetics.
[56] E. Hey,et al. Death in infancy from unrecognised congenital heart disease. , 1994, Archives of disease in childhood.
[57] R. R. Wolfe,et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. , 1993, Circulation.
[58] H. Schieffer,et al. Acute effects of intravenous milrinone in heart failure. , 1989, European heart journal.
[59] S. Lahiri,et al. Normalization of the blunted ventilatory response to acute hypoxia in congenital cyanotic heart disease. , 1977, The New England journal of medicine.
[60] O. Lloyd,et al. A CASE OF ANOMALOUS LEFT CORONARY ARTERY , 1951, British heart journal.
[61] S. Gottlieb. Chapter 44 – Management of Volume Overload in Heart Failure , 2011 .
[62] M. Froeschl,et al. Thyrotoxicosis-an uncommon cause of heart failure. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[63] Ling-Fu Meng. Nesiritide in Infants and Children with Congestive Heart Failure , 2005 .
[64] E. Gilbert-Barness. Review: Metabolic cardiomyopathy and conduction system defects in children. , 2004, Annals of clinical and laboratory science.
[65] H. Schultheiss,et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. , 2003, Circulation.
[66] J. Towbin,et al. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. , 2000, Circulation.
[67] W. Remme,et al. Preload-dependent hemodynamic effects of milrinone in moderate heart failure. , 1992, Cardiology.
[68] G. Giboney,et al. Ventricular septal defect , 2018, Operative Cardiac Surgery.
[69] G R HERRMANN,et al. Congestive heart failure. , 1962, Geriatrics.
[70] S. Griffiths,et al. Ventricular septal defect. I. Congestive heart failure in infancy. , 1960, Pediatrics.